Eppen_TracePCR_Dec24
  Editorial
 HEAVENS WILL NOT FALL   
 Wednesday, December 31, 2025 
 For the pharmaceutical companies with a turnover of less than Rs. 250 crore, time is ticking away fast to implement the Revised Schedule M. According to reports, a large number of MSME units, especially small and 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]BioAtla and GATC Health announce $40 million SPV transaction to advance ozuriftamab vedotin into a registrational trial for 2L+ OPSCC
17:00  [IST]Novo Nordisk announces China’s Supreme People’s Court delivers positive ruling on semaglutide compound patent
16:00  [IST]Hoth Therapeutics expands oncology pipeline with dual patent filings establishing novel oncology dermatology IP platform
15:00  [IST]Delcath Systems announces publication of subgroup analyses of phase 3 FOCUS study of Melphalan/Hepatic Delivery System in patients with unresectable metastatic uveal melanoma
14:00  [IST]Corcept receives US FDA Complete Response Letter for relacorilant as a treatment for patients with hypercortisolism
13:00  [IST]Xortx Therapeutics announces pioneering research on genome-wide pathogenic pathways in gout
more news >>
TOP NEWS
08:00  [IST]DoP calls for proposals for two sub-schemes under strengthening of medical device industry
08:00  [IST]Commerce ministry launches market access support under EPM-NIRYAT DISHA to boost exports
08:00  [IST]Haryana & Telangana begin crackdown on nimesulide above 100 mg in immediate-release dosage forms
08:00  [IST]India’s vision health signals paradigm shift with precision innovation in cataract surgery & myopia lenses
08:00  [IST]India bolsters medical transportation with technology to bring in reliability in patient travel
08:00  [IST]DoP includes member of HTAIn in expert committee on pricing of drugs
more news >>
YESTERDAY'S NEWS
18:00  [IST]Valneva and Serum Institute of India discontinue chikungunya vaccine license agreement
17:00  [IST]Union health minister releases 10th edition of Indian Pharmacopoeia 2026
16:00  [IST]Mabwell's adalimumab biosimilar receives Indonesian FDA marketing approval
15:00  [IST]US FDA approves Vanda Pharma’s Nereus, an oral NK-1 receptor antagonist for prevention of vomiting induced by motion
13:45  [IST]New leadership elected for Telangana State Chemists and Druggists Association
12:30  [IST]Ministry of Ayush to inaugurate 9th Siddha Day celebrations in Chennai on January 3
more news >>
INTERVIEW  
Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training
Lalit Kumar Goel, State Drug Controller (SDC) of Haryana
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
Avians_2025
                                                         
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram